NICKESHA BROWN-FOKUO: Open Payments
NPI 1336900331 · WEST HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,336 in 105 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $1,444 · 2025 $2,336
Food & beverage: $2,337
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 32 | $809 |
| Novo Nordisk Inc | 11 | $205 |
| Exact Sciences Corporation | 6 | $136 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $124 |
| Amgen Inc. | 6 | $120 |
| Astellas Pharma US Inc | 4 | $114 |
| ANI Pharmaceuticals, Inc. | 5 | $113 |
| Neurocrine BioSciences, Inc. | 4 | $99 |
| Lilly USA, LLC | 4 | $83 |
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
Products named: FASENRA, BREZTRI, The Cologuard Plus Collection Kit, Veozah, PURIFIED CORTROPHIN GEL, XIFAXAN, INGREZZA, FARXIGA.
Industry payments across CT — which companies pay providers there.
